Rechercher

Cécilia Maillet, Jonathan Wong So, Yanis Ramdani, Adrien Bigot, Nicole Ferreira-Maldent, Brigitte Chandenier, François Maillot, Alexandra Audemard-Verger. March 2023, page 65

Misleading isorhythmic dissociation

Charlène Fraysse, Victoria Picquendar, Marion Gardies, Livia Mannaion, Caroline Demurger. March 2023, page 66

Living with… a lymphoma

Guy Bouguet. March 2023, page 69

First malaria vaccine recommended by WHO

RST,S/AS01, the first WHO recommended vaccine against malaria, is the result of decades of research. It is a recombinant protein vaccine which induces a protection against Plasmodium falciparum...

Wendé-Waoga Guillaume Zango, Marie-Fleur Durieux, Jean-François Faucher. March 2023, page 71

Neuromyelitis optica

Neuromyelitis optica (NMO) or neuromyelitis optica spectrum disorder (NMOSD) includes different inflammatory conditions of the central nervous system distinct from multiple sclerosis. It is...

Thomas Roux, Élisabeth Maillart, Caroline Papeix. March 2023, page 77

Addiction to cannabis, cocaine, amphetamines, opiates, synthetic drugs

Laurent Karila, Amine Benyamina. March 2023, page 85

Opioid substitution therapy and harm reduction

Laurent Karila, Amine Benyamina. March 2023, page 94

Representations of death and relationship to death. Anthropological and psycho-existential approaches

Gilles Moutot, Delphine Peyrat-Apicella, Guillaume Grandazzi, Guillaume Robert. March 2023, page 96

The anthropological rupture linked to the pandemic

Gilles Moutot, Delphine Peyrat-Apicella, Guillaume Grandazzi, Guillaume Robert. March 2023, page 102

Analyze and use the results of clinical studies in the perspective of good use. Critical analysis, clinical research and levels of evidence

Antoine Pariente, Sibylle de Germay. March 2023, page 103

The history of the Reichsuniversität Straßburg revealed

Christian Bonah, Loïc Lutz. March 2023, page 118

New antibiotics to deal with antibiotic resistance

The current increase in antibiotic resistance exposes to the risk of therapeutic impasse. To deal with this public health problem, developing new antibiotics that are effective (directly or in...

Pauline Huriez, Benoît Pilmis. September 2023, page 6

Evolutions of the "framework of benefits" system

In the field of compliance, the last thirty years have been marked by an evolution of the regulatory framework in order to adapt an anti-corruption system to the whole ecosystem of health...

Marianne Lahana, Frédéric Glicenstein. September 2023, page 15

The history of Hodgkin lymphoma

Hodgkin lymphoma was initially considered to be caused by infectious agents. The Hodgkin and Reed-Sternberg tumor cells are derived from mature B cells and transforming events were identified....

Christophe Fermé. September 2023, page 21

Epidemiology of classical Hodgkin lymphoma

Classical Hodgkin lymphoma is a rare neoplasia but represents one of the most common cancers in adults younger than 40 years old. Epidemiology of Hodgkin lymphoma remains fascinating with specific...

Hervé Ghesquières. September 2023, page 25

A better understanding of biological mechanisms

Hervé Ghesquières. September 2023, page 29

Diagnosis and staging of Hodgkin lymphoma

Hodgkin lymphoma (HL) is composed of two distinct disease entities: classical HL (cHL) and nodular lymphocyte predominant HL (NLPHL). NLPHL is a rare entity with a specific therapeutic management....

Hervé Ghesquières. September 2023, page 31

Positron emission tomography: a central role in assessment and evaluation

Salim Kanoun. September 2023, page 35

Frontline therapy for classical Hodgkin lymphoma patients

Upfront first-line chemotherapy is indicated for all features of classical Hodgkin's lymphoma, followed by involved node radiotherapy in early stages; the ABVD protocol (doxorubicin (Adriamycin),...

Cédric Rossi, Olivier Casasnovas. September 2023, page 39

Relapse of Hodgkin lymphoma: second and subsequent line treatments

Patients who fail first-line treatment can be cured with salvage chemotherapy followed by intensified therapy and hematopoietic stem cell autotransplantation. This treatment strategy is feasible...

Bénédicte Deau Fischer. September 2023, page 48

Toxicity of targeted therapies and immunotherapy with checkpointinhibitors in Hodgkin lymphoma

In patients at increased risk of recurrence or progression after autotransplantation, or in cases of relapse after autotransplantation or after at least two lines of treatment when intensive...

Jean-Marie Michot, Julien Lazarovici. September 2023, page 58

Fertility and gonadal disorders in patients with Hodgkin lymphoma

Christine Rousset-Jablonski. September 2023, page 69

Ollier disease

Habib Bellamlih, Oumaima El Bouazzi, Soufiane Belabbes, Abdellatif El Haddad, Brahim Zinoun, Taoufik Africha. September 2023, page 76

Cedell fracture

Xavier Fouilland, Cécile Imfeld. September 2023, page 77

Alcohol consumption and high blood pressure

Cardiovascular disease is the second leading cause of alcohol-attributable mortality after cancer. The impact of alcohol consumption on blood pressure and the risk of cardiovascular pathologies are...

Mickael Naassila, Naouras Bouajila, Daniel Thomas, Henri-Jean Aubin. September 2023, page 81

Impact of the environment on health. Part 1. Child: the concept of the first 1 000 days

Umberto Simeoni, Jean-Baptiste Armengaud. September 2023, page 91

Biotherapies for the treatment of ulcerative colitis

The treatment of ulcerative colitis has evolved considerably since it must, for most patients, allow healing of inflammatory colonic lesions and no longer a simple remission of clinical symptoms....

Xavier Treton. June 2023, page 8

Therapeutic advances in HER2+ breast cancer

58,000 new cases of breast cancer occured in France in 2018, of which 15-20% are HER2-positive. HER2-targeted therapies deeply modified the management of these tumors, first by the introduction of...

Marie Alexandre, William Jacot. June 2023, page 33

Social media and teenagers' mental health

Social media are widely used daily especially amongst adolescents. The fast apparition and evolution of these platforms might be difficult to follow. Social Media can expose to risks that it is...

Natalia Robert, Nathalie Godart. June 2023, page 22

Epidemiology and pathophysiology of giant cell arteritis

Giant cell arteritis (GCA) is a granulomatous vasculitis. It affects patients over 50 years of age, predominantly women. The pathophysiology of GCA involves genetic and environmental factors...

Hélène Greigert, Bernard Bonnotte, Maxime Samson. June 2023, page 39

Diagnosis of giant cell arteritis

The diagnosis of giant cell arteritis (GCA) must be made promptly in order to initiate appropriate treatment aimed at relieving symptoms and avoiding ischemic complications, particularly visual...

Hélène Greigert, Bernard Bonnotte, Maxime Samson. June 2023, page 46

Treatment of giant cell arteritis

The treatment of giant cell arteritis (GCA) is based on glucocorticoids. This treatment significantly reduces the risk of ischemic complications, especially those of a visual nature, rapidly...

Maxime Samson, Hélène Greigert, Bernard Bonnotte. June 2023, page 55

Takayasu's arteritis

Takayasu’s arteritis is an inflammatory panarteritis of the large vessels, preferentially affecting the aorta, its main branches, and the pulmonary arteries. Its incidence is estimated at 1.11...

Alexis F Guédon, Raphaël Bourgade, Mounia Elhannani, Claire Toquet, Olivier Espitia, Olivier Fain, Arsène Mekinian. June 2023, page 60

Vasculitis of large-caliber vessels: 10 key messages

Maxime Samson, Hélène Greigert, Bernard Bonnotte. June 2023, page 67

Carcinoma, Non-Small-Cell Lung

Benjamin Teboul, Étienne Ghrenassia. June 2023, page 70

Post-zoster segmental abdominal paralysis

Christian Brosset, Hien Nguyen Quang, Anh Giang Thuc, François Pruvot, Tu Do Van. June 2023, page 73

Bilateral axillary supernumerary breasts

Kaoutar Sof, Hasnae Saddouk, Hanane Daflaoui, Ghita Cherkaoui, Ayat Allah Oufkir, Nada Zizi, Siham Dikhaye. June 2023, page 74

Unilateral edema of the upper limb

Matthieu Bellakehal, Joris Marti, Claire Lequesne, Albane Buan. June 2023, page 76

Folliculitis decalvans on a cutis verticis gyrata

Sara Bouabdella, Soraya Aouali, Siham Dikhaye, Nada Zizi. June 2023, page 79

Exploration and management of thyroid nodules

Most thyroid nodules are benign (95%) and can benefit from clinical and ultrasound monitoring. Cancers (approximately 5% of nodules) could be suspected, particularly in subjects whose neck was...

Hamza Benderradji, Christine Do Cao, Miriam Ladsous, Jean-Louis Wémeau. June 2023, page 95